Jean-Louis Pasquali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jean-Louis Pasquali has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Anne-Sophie Korganow
Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, University Hospitals of Strasbourg, Strasbourg, France
5 shared publications Thierry Martin
CNRS UPR 9021, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France
4 shared publications- Thierry Martin
Department of Clinical Immunology and Internal Medicine, Strasbourg University Hospitals, Strasbourg, Grand Est, France
4 shared publications - Pauline Soulas-Sprauel
CNRS UPR 3572 "Immunopathology and Therapeutic Chemistry"/Laboratory of Excellence Medalis, Institute of Molecular and Cellular Biology (IBMC), Strasbourg, France; Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; UFR Sciences Pharmaceutiques, Université de Strasbourg, Illkirch-Graffenstaden, France
3 shared publications Anne-Marie Knapp
CNRS UPR 9021, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France
2 shared publicationsVincent Poindron
2 shared publications
Latest Publications
- 1 April 2012
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 33 (4) , 189-193
Aspects immunologiques du syndrome des antiphospholipides
- 1 April 2012
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 33 (4) , 189-193
Aspects immunologiques du syndrome des antiphospholipides
- Open Access
- 23 August 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (8) , e23900
B Cell Signature during Inactive Systemic Lupus Is Heterogeneous: Toward a Biological Dissection of Lupus
Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biological heterogeneity. B lymphocytes appear central to the development of SLE which is characterized by the production of a large variety of autoantibodies and hypergammaglobulinemia. In mice, immature B cells from spontaneous lupus prone animals are able to produce autoantibodies when transferred into immunodeficient mice, strongly suggesting the existence of intrinsic B cell defects during lupus. In order to approach these defects in humans, we compared the peripheral B cell transcriptomas of quiescent lupus patients to normal B cell transcriptomas. When the statistical analysis is performed on the entire group of patients, the differences between patients and controls appear quite weak with only 14 mRNA genes having a false discovery rate ranging between 11 and 17%, with 6 underexpressed genes (PMEPA1, TLR10, TRAF3IP2, LDOC1L, CD1C and EGR1). However, unforced hierarchical clustering of the microarrays reveals a subgroup of lupus patients distinct from both the controls and the other lupus patients. This subgroup has no detectable clinical or immunological phenotypic peculiarity compared to the other patients, but is characterized by 1/an IL-4 signature and 2/the abnormal expression of a large set of genes with an extremely low false discovery rate, mainly pointing to the biological function of the endoplasmic reticulum, and more precisely to genes implicated in the Unfolded Protein Response, suggesting that B cells entered an incomplete BLIMP1 dependent plasmacytic differentiation which was undetectable by immunophenotyping. Thus, this microarray analysis of B cells during quiescent lupus suggests that, despite a similar lupus phenotype, different biological roads can lead to human lupus.
- 23 August 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (8) , e23900
Open AccessB Cell Signature during Inactive Systemic Lupus Is Heterogeneous: Toward a Biological Dissection of Lupus
Systemic lupus erythematosous (SLE) is an autoimmune disease with an important clinical and biological heterogeneity. B lymphocytes appear central to the development of SLE which is characterized by the production of a large variety of autoantibodies and hypergammaglobulinemia. In mice, immature B cells from spontaneous lupus prone animals are able to produce autoantibodies when transferred into immunodeficient mice, strongly suggesting the existence of intrinsic B cell defects during lupus. In order to approach these defects in humans, we compared the peripheral B cell transcriptomas of quiescent lupus patients to normal B cell transcriptomas. When the statistical analysis is performed on the entire group of patients, the differences between patients and controls appear quite weak with only 14 mRNA genes having a false discovery rate ranging between 11 and 17%, with 6 underexpressed genes (PMEPA1, TLR10, TRAF3IP2, LDOC1L, CD1C and EGR1). However, unforced hierarchical clustering of the microarrays reveals a subgroup of lupus patients distinct from both the controls and the other lupus patients. This subgroup has no detectable clinical or immunological phenotypic peculiarity compared to the other patients, but is characterized by 1/an IL-4 signature and 2/the abnormal expression of a large set of genes with an extremely low false discovery rate, mainly pointing to the biological function of the endoplasmic reticulum, and more precisely to genes implicated in the Unfolded Protein Response, suggesting that B cells entered an incomplete BLIMP1 dependent plasmacytic differentiation which was undetectable by immunophenotyping. Thus, this microarray analysis of B cells during quiescent lupus suggests that, despite a similar lupus phenotype, different biological roads can lead to human lupus.
- 1 October 2008
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 22 (5) , 831-845
The antiphospholipid syndrome
- 1 October 2008
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 22 (5) , 831-845
The antiphospholipid syndrome
- 1 December 2007
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 28, S302-S303
Physiopathologie du syndrome des antiphospholipides
- 1 December 2007
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 28, S302-S303
Physiopathologie du syndrome des antiphospholipides
- 1 December 2007
- Published by Elsevier in Journal of Autoimmunity
- Vol. 29 (4) , 250-256
Auto-reactive B cells in transgenic mice
- 1 December 2007
- Published by Elsevier in Journal of Autoimmunity
- Vol. 29 (4) , 250-256
Auto-reactive B cells in transgenic mice
- 1 April 2007
- Published by Elsevier in La Presse Médicale
- Vol. 36 (4) , 667-673
Physiopathologie du syndrome des antiphospholipides
- 1 April 2007
- Published by Elsevier in La Presse Médicale
- Vol. 36 (4) , 667-673
Physiopathologie du syndrome des antiphospholipides
- 10 November 2004
- Published by Wiley in Journal of Molecular Recognition
- Vol. 18 (3) , 254-261
T-cell receptor Vβ gene usage in CSF lymphocytes in X-linked adrenoleukodystrophy
X-linked adrenoleukodystrophy (ALD) is a peroxisomal disorder with impaired very-long-chain fatty acid (VLCFA) metabolism that produces a neurological disease with significant variability of clinical phenotypes even within kindred. The two most common forms are the cerebral form (CALD) with an important inflammatory reaction at the active edge of demyelinating lesions, resembling some aspects of multiple sclerosis pathology, and adrenomyeloneuropathy (AMN), which involves the spinal cord and in which the inflammatory reaction is mild or absent. One hypothesis is that the phenotypic variability is related to T cell-mediated immune mechanisms playing a primary role in the demyelinating pathogenic process of CALD. The present study aims to test the hypothesis that CSF of patients with the CALD form contains highly restricted T cell populations. The variable regions of the T cell receptor β chains (TCR Vβ) were studied in CSF from 29 ALD patients with different phenotypes. RNA was extracted and cDNA synthesized from CSF lymphocytes; TCR Vβ gene segments were amplified from the cDNA by polymerase chain reaction (PCR) using 20 family-specific primers. PCR products were analyzed by Southern blot. Some amplified Vβ products were sequenced. The majority of ALD patients (21/29), whatever their phenotype, exhibited oligoclonal T cell expansion. However the overexpression of some TCR Vβ families was heterogeneous among the different patients without any preponderance of specific Vβ families or any clustering according to clinical phenotype. In particular a dominant TCR Vβ utilization was not found in patients with CALD. Copyright © 2004 John Wiley & Sons, Ltd.
- 10 November 2004
- Published by Wiley in Journal of Molecular Recognition
- Vol. 18 (3) , 254-261
T-cell receptor Vβ gene usage in CSF lymphocytes in X-linked adrenoleukodystrophy
X-linked adrenoleukodystrophy (ALD) is a peroxisomal disorder with impaired very-long-chain fatty acid (VLCFA) metabolism that produces a neurological disease with significant variability of clinical phenotypes even within kindred. The two most common forms are the cerebral form (CALD) with an important inflammatory reaction at the active edge of demyelinating lesions, resembling some aspects of multiple sclerosis pathology, and adrenomyeloneuropathy (AMN), which involves the spinal cord and in which the inflammatory reaction is mild or absent. One hypothesis is that the phenotypic variability is related to T cell-mediated immune mechanisms playing a primary role in the demyelinating pathogenic process of CALD. The present study aims to test the hypothesis that CSF of patients with the CALD form contains highly restricted T cell populations. The variable regions of the T cell receptor β chains (TCR Vβ) were studied in CSF from 29 ALD patients with different phenotypes. RNA was extracted and cDNA synthesized from CSF lymphocytes; TCR Vβ gene segments were amplified from the cDNA by polymerase chain reaction (PCR) using 20 family-specific primers. PCR products were analyzed by Southern blot. Some amplified Vβ products were sequenced. The majority of ALD patients (21/29), whatever their phenotype, exhibited oligoclonal T cell expansion. However the overexpression of some TCR Vβ families was heterogeneous among the different patients without any preponderance of specific Vβ families or any clustering according to clinical phenotype. In particular a dominant TCR Vβ utilization was not found in patients with CALD. Copyright © 2004 John Wiley & Sons, Ltd.
- 1 January 1993
- Published by Taylor & Francis in Autoimmunity
- Vol. 16 (3) , 215-224
Analysis of the V kappa III Variable Regions of Polyclonal Rheumatoid Factors Arising During Epstein Barr Virus Induced Infectious Mononucleosis
The mechanisms that govern autoantibody production are still under debate. In particular, auto-antibodies can appear as a consequence of a polyclonal activation of B cells or as a consequence of an antigen driven B cell expansion. The molecular analysis of the variable regions of auto-antibodies arising during different clinical situations can help to understand the origin of auto-antibodies. We recently described the main light chain variable regions of polyclonal rheumatoid factors occuring during rheumatoid arthritis and suggested that the mutation pattern of these regions could reflect an antigen driven process. Using the same approach, we now report the molecular analysis of the same light chain variable region containing a VKIII segment of rheumatoid factors originating from a polyclonal activation of B cells during an in vivo Epstein-Barr virus infection, infectious mononucleosis. The cDNA derived from rheumatoid factor synthetizing cells were amplified by two sets of polymerase chain reaction. The amplified products were cloned in M13mp 19 phages and sequenced. The nucleotide analysis of the VKIII containing VK regions shows that: 1) the rheumatoid factor activity is associated with the 3 VKIII genes (Kv 325, Kv 328 and Vg) already known to encode for monoclonal and polyclonal rheumatoid factors, 2) there is a preferential use of Kv 328 and Vg, each one of these genes being poorly mutated, 3) the CDR mutation rates of these genes is no higher than the framework mutation rates, 4) there is a restriction of the JK usage: Kv 328 derived gene segments rearrange exclusively with JK1, Vg preferentially rearranges with JK1 and JK4. These results mainly suggest that naturally occuring polyclonal activation of autoreactive B cells produces poorly mutated autoantibodies.
- 1 January 1993
- Published by Taylor & Francis in Autoimmunity
- Vol. 16 (3) , 215-224
Analysis of the V kappa III Variable Regions of Polyclonal Rheumatoid Factors Arising During Epstein Barr Virus Induced Infectious Mononucleosis
The mechanisms that govern autoantibody production are still under debate. In particular, auto-antibodies can appear as a consequence of a polyclonal activation of B cells or as a consequence of an antigen driven B cell expansion. The molecular analysis of the variable regions of auto-antibodies arising during different clinical situations can help to understand the origin of auto-antibodies. We recently described the main light chain variable regions of polyclonal rheumatoid factors occuring during rheumatoid arthritis and suggested that the mutation pattern of these regions could reflect an antigen driven process. Using the same approach, we now report the molecular analysis of the same light chain variable region containing a VKIII segment of rheumatoid factors originating from a polyclonal activation of B cells during an in vivo Epstein-Barr virus infection, infectious mononucleosis. The cDNA derived from rheumatoid factor synthetizing cells were amplified by two sets of polymerase chain reaction. The amplified products were cloned in M13mp 19 phages and sequenced. The nucleotide analysis of the VKIII containing VK regions shows that: 1) the rheumatoid factor activity is associated with the 3 VKIII genes (Kv 325, Kv 328 and Vg) already known to encode for monoclonal and polyclonal rheumatoid factors, 2) there is a preferential use of Kv 328 and Vg, each one of these genes being poorly mutated, 3) the CDR mutation rates of these genes is no higher than the framework mutation rates, 4) there is a restriction of the JK usage: Kv 328 derived gene segments rearrange exclusively with JK1, Vg preferentially rearranges with JK1 and JK4. These results mainly suggest that naturally occuring polyclonal activation of autoreactive B cells produces poorly mutated autoantibodies.
- 1 January 1989
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (5) , 591-592
Ceftriaxone-induced granulopenia related to a peculiar mechanism of granulopoiesis inhibition
- 1 January 1989
- Published by Elsevier in The American Journal of Medicine
- Vol. 87 (5) , 591-592
Ceftriaxone-induced granulopenia related to a peculiar mechanism of granulopoiesis inhibition